LexaMed is pleased to announce the addition of David J. Brodersen to our executive management team. David will serve as LexaMed’s Director of Technical Services and Strategic Initiatives where he will focus on the management of several of LexaMed’s services in the areas of sterilization, validation and microbiological-compliance. David is a global quality leader who has extensive knowledge in Quality Assurance, Risk Management, Microbiology, Sterilization and Biocompatibility. David joins LexaMed from Covidien, where he held several positions including Director of Sterilization and Director of Quality Assurance. David is active in several professional organizations including AAMI, PDA, American Society for Microbiology, American Society of Quality, and Pharmaceutical Microbiology Forum. LexaMed is thrilled to have David join our team and we know he will be an invaluable asset. Welcome aboard, David!
http://lexamed.net/wp-content/uploads/2017/03/Blue-Lex-Logo-300x86.png 0 0 computol http://lexamed.net/wp-content/uploads/2017/03/Blue-Lex-Logo-300x86.png computol2015-04-27 13:03:342015-04-30 14:08:32David Brodersen Joins LexaMed’s Executive Management Team